CGA and neoplasm: Figure 3 shows Kaplan–Meier plots for the progression-free survival of patients with GEP-NET during 24 months of follow-up, stratified by the primary tumor site (A), presence of autonomous hormone secretion syndrome (B), tumor grade (C), treatment type (D), and baseline CgA (E).